Dren Bio

Sponsors visas
Lately:1 news story in 90 daysFollow changes →

Facts

as of Nov 17, 2026
Legal name
Dren Bio, Inc.
Headquarters
Foster City, United States
Founded
2019
Employees
201-500estimated range
Register numbers
NAME dren bio inc
Official records
SEC CIK 1783374
Website
drenbio.com

These are the key facts about Dren Bio on Alion as of Nov 17, 2026. Dren Bio is headquartered in Foster City, United States. It was founded in 2019. It has raised $443.1M in 4 funding rounds. The latest round is Venture - Series Unknown of $350M, announced in 2026.

Sources: company registers, GLEIF, Wikidata, the company's site, Alion job postingsReport a mistake

What the registers and the postings say about this employer.

Legal entity active
Dren Bio, Inc.
Not checked
Sanctions lists
OFAC SDN, EU consolidated
No match
Phishing reports
OpenPhish, Phishing.Database
None
Layoff notices
US WARN notices on file
None
Full employer checkScam signs in adverts, mail records, visa registers, domain history
Sources: company registers, the Alion truth index, OFAC and EU sanctions lists, US WARN notices

Named in the work visa registers of United States.

0H-1B filings in 12 months
0Open roles in United States

In the register as Dren Bio, Inc., Foster City, CA

Alert me
US Department of Labor · latest filing May 2, 2025

Footprint

Hiring in 1 city in 1 country.

1Cities
1Countries
SiteTypeOpen rolesHires most forEngineering
Foster City United StatesHeadquarters0
Source: office addresses in postings and company registers

Financials

Funding rounds, investors and revenue on record.

$443.1MTotal raised
Venture - Series UnknownLatest round
4Rounds and grants
Money by yearUSD, rounds and grants
2026$350M1 record
2022$62.5M1 record
2020$25.5M1 record
2019$5.1M1 record
Largest rounds and grants
Sources: funding announcements, grant and company registers

Milestones

Mar 16, 2022
2019
Founded
Each milestone is dated by its source: registers, filings, the press

Newsroom

Oct 302026
News · Pulse 2.0
Dren Bio has closed an oversubscribed $350 million private financing to advance its lead antibody therapy dibotatug toward regulatory submission and commercialization while expan…
Sources: the outlets named on each headline, each story once